CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 2 filers reported holding CARA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $2,601 | -90.3% | 3,500 | -78.1% | 0.00% | -100.0% |
| Q3 2023 | $26,909 | -40.6% | 16,017 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $45,328 | -42.4% | 16,017 | 0.0% | 0.00% | -42.9% |
| Q1 2023 | $78,643 | -58.2% | 16,017 | -8.6% | 0.01% | -58.8% |
| Q4 2022 | $188,133 | +9.4% | 17,517 | -4.4% | 0.02% | -29.2% |
| Q3 2022 | $172,000 | +3.0% | 18,327 | 0.0% | 0.02% | +9.1% |
| Q2 2022 | $167,000 | -25.1% | 18,327 | 0.0% | 0.02% | -8.3% |
| Q1 2022 | $223,000 | +41.1% | 18,327 | +41.0% | 0.02% | +50.0% |
| Q4 2021 | $158,000 | -36.0% | 13,000 | -18.8% | 0.02% | -40.7% |
| Q3 2021 | $247,000 | +8.3% | 16,000 | 0.0% | 0.03% | +8.0% |
| Q2 2021 | $228,000 | -31.5% | 16,000 | +4.4% | 0.02% | -37.5% |
| Q1 2021 | $333,000 | +34.8% | 15,327 | -6.1% | 0.04% | +29.0% |
| Q4 2020 | $247,000 | +13.8% | 16,327 | -4.1% | 0.03% | +3.3% |
| Q3 2020 | $217,000 | -25.4% | 17,027 | 0.0% | 0.03% | -30.2% |
| Q2 2020 | $291,000 | +29.3% | 17,027 | 0.0% | 0.04% | +10.3% |
| Q1 2020 | $225,000 | -37.5% | 17,027 | -23.8% | 0.04% | -22.0% |
| Q4 2019 | $360,000 | -12.0% | 22,354 | 0.0% | 0.05% | -19.4% |
| Q3 2019 | $409,000 | -15.0% | 22,354 | 0.0% | 0.06% | -12.7% |
| Q2 2019 | $481,000 | +9.6% | 22,354 | 0.0% | 0.07% | +9.2% |
| Q1 2019 | $439,000 | +50.9% | 22,354 | 0.0% | 0.06% | +32.7% |
| Q4 2018 | $291,000 | -45.6% | 22,354 | 0.0% | 0.05% | -34.7% |
| Q3 2018 | $535,000 | +19.7% | 22,354 | -4.3% | 0.08% | +8.7% |
| Q2 2018 | $447,000 | +54.7% | 23,354 | 0.0% | 0.07% | +46.8% |
| Q1 2018 | $289,000 | +1.0% | 23,354 | 0.0% | 0.05% | +4.4% |
| Q4 2017 | $286,000 | -10.6% | 23,354 | 0.0% | 0.04% | -11.8% |
| Q3 2017 | $320,000 | -10.9% | 23,354 | 0.0% | 0.05% | -12.1% |
| Q2 2017 | $359,000 | -16.3% | 23,354 | 0.0% | 0.06% | -18.3% |
| Q1 2017 | $429,000 | +20.5% | 23,354 | -39.1% | 0.07% | +10.9% |
| Q4 2016 | $356,000 | +8.2% | 38,354 | -2.5% | 0.06% | +6.7% |
| Q3 2016 | $329,000 | +74.1% | 39,354 | 0.0% | 0.06% | +53.8% |
| Q2 2016 | $189,000 | -37.8% | 39,354 | -19.4% | 0.04% | -29.1% |
| Q1 2016 | $304,000 | -65.3% | 48,854 | -6.1% | 0.06% | -61.5% |
| Q4 2015 | $877,000 | +18.0% | 52,029 | 0.0% | 0.14% | +14.4% |
| Q3 2015 | $743,000 | +17.6% | 52,029 | 0.0% | 0.12% | +33.0% |
| Q2 2015 | $632,000 | +19.7% | 52,029 | -1.0% | 0.09% | +20.5% |
| Q1 2015 | $528,000 | +0.8% | 52,529 | 0.0% | 0.08% | +2.6% |
| Q4 2014 | $524,000 | +18.3% | 52,529 | -0.6% | 0.08% | +20.6% |
| Q3 2014 | $443,000 | +40.6% | 52,829 | +185.6% | 0.06% | +34.0% |
| Q2 2014 | $315,000 | +25.5% | 18,500 | +37.0% | 0.05% | +17.5% |
| Q1 2014 | $251,000 | – | 13,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,204,449 | $10,824 | 1.35% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,233,000 | $6,054,030 | 1.14% |
| Chescapmanager LLC | 1,160,392 | $5,698 | 0.90% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,732,375 | $8,505,961 | 0.22% |
| XTX Topco Ltd | 107,610 | $528,365 | 0.11% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 84,530 | $415,042 | 0.08% |
| PINNACLE ASSOCIATES LTD | 679,413 | $3,335,918 | 0.07% |
| PDT Partners, LLC | 102,010 | $500,869 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,370 | $9,797,267 | 0.05% |
| AXQ CAPITAL, LP | 27,760 | $136,302 | 0.05% |